About this data
What it is
When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
Who files it
The insider, usually through the company, within two business days of the trade.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.

All of this comes from public filings.

Open-market trades per day, last 30 days

05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0
05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0

Purchases Sales

By trade date. Insiders have two business days to file, so the most recent days fill in later.

Latest open-market insider trades

Reset

Showing: ticker CRSP

Latest open-market insider trades
TradedInsiderCompanyTypeSharesPriceValueFiling
Oct 19, 2026Samarth Kulkarni
Chief Executive Officer, Director
CRSP
CRISPR Therapeutics AG
Sale47,837$49.78$2.4M SaleForm 4 ↗
Oct 14, 2026George Simeon
Director
CRSP
CRISPR Therapeutics AG
Sale14,514$49.63$720.4K SaleForm 4 ↗
Sep 22, 2026James R. Kasinger
General Counsel and Secretary
CRSP
CRISPR Therapeutics AG
Sale10,400$60.24$626.5K SaleForm 4 ↗
Sep 17, 2026Ali Behbahani
Director
CRSP
CRISPR Therapeutics AG
Sale13,679$57.09$780.9K SaleForm 4 ↗
May 29, 2026Naimish Patel
Chief Medical Officer
CRSP
CRISPR Therapeutics AG
Sale3,786$55.62$210.6K SaleForm 4 ↗
Mar 23, 2026James R. Kasinger
General Counsel and Secretary
CRSP
CRISPR Therapeutics AG
Sale3,182$46.78$148.9K SaleForm 4 ↗
Mar 23, 2026Samarth Kulkarni
Chief Executive Officer, Director
CRSP
CRISPR Therapeutics AG
Sale10,020$46.78$468.7K SaleForm 4 ↗
Mar 23, 2026Raju Prasad
Chief Financial Officer
CRSP
CRISPR Therapeutics AG
Sale3,708$46.78$173.5K SaleForm 4 ↗
Mar 16, 2026Naimish Patel
Chief Medical Officer
CRSP
CRISPR Therapeutics AG
Sale3,150$48.26$152.0K SaleForm 4 ↗
Mar 16, 2026Raju Prasad
Chief Financial Officer
CRSP
CRISPR Therapeutics AG
Sale4,021$48.26$194.1K SaleForm 4 ↗
Mar 16, 2026Raju Prasad
Chief Financial Officer
CRSP
CRISPR Therapeutics AG
Sale5,848$48.26$282.2K SaleForm 4 ↗
Mar 16, 2026James R. Kasinger
General Counsel and Secretary
CRSP
CRISPR Therapeutics AG
Sale3,450$48.26$166.5K SaleForm 4 ↗
Mar 16, 2026Samarth Kulkarni
Chief Executive Officer, Director
CRSP
CRISPR Therapeutics AG
Sale10,349$48.26$499.4K SaleForm 4 ↗
Mar 11, 2026James R. Kasinger
General Counsel and Secretary
CRSP
CRISPR Therapeutics AG
Sale2,800$52.80$147.8K SaleForm 4 ↗
Mar 11, 2026Samarth Kulkarni
Chief Executive Officer, Director
CRSP
CRISPR Therapeutics AG
Sale9,798$52.80$517.3K SaleForm 4 ↗
Feb 19, 2026Samarth Kulkarni
Chief Executive Officer, Director
CRSP
CRISPR Therapeutics AG
Sale6,967$52.58$366.3K SaleForm 4 ↗
Feb 19, 2026James R. Kasinger
General Counsel and Secretary
CRSP
CRISPR Therapeutics AG
Sale2,112$52.58$111.0K SaleForm 4 ↗
Jan 22, 2026Raju Prasad
Chief Financial Officer
CRSP
CRISPR Therapeutics AG
Sale34,972$60.19$2.1M SaleForm 4 ↗
Jan 22, 2026Samarth Kulkarni
Chief Executive Officer, Director
CRSP
CRISPR Therapeutics AG
Sale60,000$60.23$3.6M SaleForm 4 ↗
Jan 20, 2026Samarth Kulkarni
Chief Executive Officer, Director
CRSP
CRISPR Therapeutics AG
Sale8,567$52.10$446.3K SaleForm 4 ↗
Jan 20, 2026Samarth Kulkarni
Chief Executive Officer, Director
CRSP
CRISPR Therapeutics AG
Sale21,433$51.61$1.1M SaleForm 4 ↗
Jan 6, 2026Raju Prasad
Chief Financial Officer
CRSP
CRISPR Therapeutics AG
Sale5,763$60.21$347.0K SaleForm 4 ↗
Jan 6, 2026Raju Prasad
Chief Financial Officer
CRSP
CRISPR Therapeutics AG
Sale5,004$60.00$300.2K SaleForm 4 ↗
Jan 6, 2026Raju Prasad
Chief Financial Officer
CRSP
CRISPR Therapeutics AG
Sale18,933$60.18$1.1M SaleForm 4 ↗
Dec 22, 2025Raju Prasad
Chief Financial Officer
CRSP
CRISPR Therapeutics AG
Sale1,000$56.89$56.9K SaleForm 4 ↗
Dec 22, 2025Raju Prasad
Chief Financial Officer
CRSP
CRISPR Therapeutics AG
Sale5,472$56.33$308.2K SaleForm 4 ↗
Dec 22, 2025Raju Prasad
Chief Financial Officer
CRSP
CRISPR Therapeutics AG
Sale3,528$55.10$194.4K SaleForm 4 ↗
Oct 17, 2025Samarth Kulkarni
Chief Executive Officer, Director
CRSP
CRISPR Therapeutics AG
Sale50,895$67.91$3.5M SaleForm 4 ↗
Oct 14, 2025Samarth Kulkarni
Chief Executive Officer, Director
CRSP
CRISPR Therapeutics AG
Sale4,242$66.60$282.5K SaleForm 4 ↗
Oct 14, 2025James R. Kasinger
General Counsel and Secretary
CRSP
CRISPR Therapeutics AG
Sale1,076$66.60$71.7K SaleForm 4 ↗
Aug 18, 2025Samarth Kulkarni
Chief Executive Officer, Director
CRSP
CRISPR Therapeutics AG
Sale13,081$58.15$760.7K SaleForm 4 ↗
Aug 6, 2025Douglas A. Treco
Director
CRSP
CRISPR Therapeutics AG
Buy20,000$57.03$1.1M BuyForm 4 ↗
Jul 16, 2025George Simeon
Director
CRSP
CRISPR Therapeutics AG
Buy960,983$52.03$50.0M BuyForm 4 ↗
Jul 16, 2025George Simeon
Director
CRSP
CRISPR Therapeutics AG
Buy22,319$52.03$1.2M BuyForm 4 ↗
Jul 16, 2025George Simeon
Director
CRSP
CRISPR Therapeutics AG
Buy6,510$52.03$338.7K BuyForm 4 ↗
May 29, 2025Naimish Patel
Chief Medical Officer
CRSP
CRISPR Therapeutics AG
Sale3,932$35.94$141.3K SaleForm 4 ↗
Apr 3, 2025Naimish Patel
Chief Medical Officer
CRSP
CRISPR Therapeutics AG
Buy1,508$32.96$49.7K BuyForm 4 ↗
Mar 21, 2025Samarth Kulkarni
Chief Executive Officer, Director
CRSP
CRISPR Therapeutics AG
Sale10,031$41.23$413.6K SaleForm 4 ↗
Mar 21, 2025Julianne Bruno
Chief Operating Officer
CRSP
CRISPR Therapeutics AG
Sale1,714$41.23$70.7K SaleForm 4 ↗
Mar 21, 2025Raju Prasad
Chief Financial Officer
CRSP
CRISPR Therapeutics AG
Sale2,197$41.23$90.6K SaleForm 4 ↗
Mar 21, 2025James R. Kasinger
General Counsel and Secretary
CRSP
CRISPR Therapeutics AG
Sale3,185$41.23$131.3K SaleForm 4 ↗
Mar 17, 2025Raju Prasad
Chief Financial Officer
CRSP
CRISPR Therapeutics AG
Sale3,762$41.80$157.3K SaleForm 4 ↗
Mar 12, 2025Samarth Kulkarni
Chief Executive Officer, Director
CRSP
CRISPR Therapeutics AG
Sale4,462$43.32$193.3K SaleForm 4 ↗
Mar 12, 2025James R. Kasinger
General Counsel and Secretary
CRSP
CRISPR Therapeutics AG
Sale1,116$43.32$48.3K SaleForm 4 ↗
Mar 12, 2025Julianne Bruno
Chief Operating Officer
CRSP
CRISPR Therapeutics AG
Sale190$43.32$8,231 SaleForm 4 ↗
Mar 11, 2025Samarth Kulkarni
Chief Executive Officer, Director
CRSP
CRISPR Therapeutics AG
Sale9,973$42.42$423.1K SaleForm 4 ↗
Mar 11, 2025James R. Kasinger
General Counsel and Secretary
CRSP
CRISPR Therapeutics AG
Sale2,850$42.42$120.9K SaleForm 4 ↗
Mar 11, 2025Julianne Bruno
Chief Operating Officer
CRSP
CRISPR Therapeutics AG
Sale1,198$42.42$50.8K SaleForm 4 ↗
Feb 26, 2025John Greene
Director
CRSP
CRISPR Therapeutics AG
Buy7,000$44.85$313.9K BuyForm 4 ↗
Feb 19, 2025Samarth Kulkarni
Chief Executive Officer, Director
CRSP
CRISPR Therapeutics AG
Sale18,360$55.21$1.0M SaleForm 4 ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:44 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances